ADAM17 and nasopharyngeal carcinoma: This study revealed that the aberrantly downregulated miR‐449b‐3p‐targeted ADAM17 promoted NPC metastasis, and ADAM17‐activated NF‐κB could transcriptionally suppress miR‐449b‐3p gene expression (Figure 7H).